News for 'Indian Immunologicals Ltd'

'Misbranded' rabies vaccine seized in Delhi, DCGI intensifies action

'Misbranded' rabies vaccine seized in Delhi, DCGI intensifies action

Rediff.com6 Sep 2026

Indian drug regulatory and law enforcement agencies have stepped up their efforts against the illegal manufacture and distribution of spurious drugs. This intensified action follows the seizure of a "misbranded" batch of Abhayrab rabies vaccine in Delhi, prompting nationwide vigilance and arrests.

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Rediff.com11 Mar 2026

For decades, multinational pharmaceutical companies and Indian drugmakers worked in ways that supported each other: MNCs brought innovation and brands, while Indian companies built scale through generics and cost efficiency. There was an important overlap - generic drugs - but this is shrinking fast. And the consequences are reshaping India's gigantic pharmaceutical market.

100 million Covaxin vaccines by Sept

100 million Covaxin vaccines by Sept

Rediff.com17 Apr 2021

The production of Covaxin will increase from the current 10 million doses per month to 60 million-70 million by July-August.

Safe to consume milk from LSD-infected cattle: IVRI official

Safe to consume milk from LSD-infected cattle: IVRI official

Rediff.com14 Sep 2022

Lumpy Skin Disease has spread in more than a dozen states including Gujarat, Rajasthan, Punjab and Haryana.

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Rediff.com17 May 2021

This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the 'capabilities and expertise' to manufacture the inactivated viral vaccines at commercial scale.

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Rediff.com6 Aug 2021

While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.

Govt exploring possibility to produce Covaxin abroad

Govt exploring possibility to produce Covaxin abroad

Rediff.com21 May 2021

To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.

How long before the world gets a COVID-19 vaccine?

How long before the world gets a COVID-19 vaccine?

Rediff.com28 Apr 2020

More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization, there are now more than 70 potential vaccines under evelopment, with some already in clinical trials.

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Rediff.com30 Sep 2021

In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.

US says Covaxin successfully neutralises Delta variant

US says Covaxin successfully neutralises Delta variant

Rediff.com30 Jun 2021

The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the United Kingdom and India, respectively.

Scientists urge caution over launch of Covid vaccine by Aug 15

Scientists urge caution over launch of Covid vaccine by Aug 15

Rediff.com4 Jul 2020

'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'